Pancreatic Cancer Breakthrough Drug
1:58–2:46 · 48s
Host introduces startling trial results on diraxsonrasib, and NPR health correspondent explains why oncologists call it the most innovative hope for pancreatic cancer patients.
1:58–2:46 · 48s
Host introduces startling trial results on diraxsonrasib, and NPR health correspondent explains why oncologists call it the most innovative hope for pancreatic cancer patients.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.